These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35715177)
1. Risk factors for COVID-19 hospitalisations and deaths in Mexican children and adolescents: retrospective cross-sectional study. Martínez-Valdez L; Richardson López Collada V; Castro-Ceronio LE; Rodríguez Gutiérrez ÁM; Bautista-Márquez A; Hernandez-Avila M BMJ Open; 2022 Jun; 12(6):e055074. PubMed ID: 35715177 [TBL] [Abstract][Full Text] [Related]
2. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study. Simpson CR; Robertson C; Vasileiou E; Moore E; McCowan C; Agrawal U; Stagg HR; Docherty A; Mulholland R; Murray JLK; Ritchie LD; McMenamin J; Sheikh A Lancet Digit Health; 2021 Aug; 3(8):e517-e525. PubMed ID: 34238721 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of hospitalization and death in Mexican children and adolescents with COVID-19 and comorbidities. Méndez-Hernández P; Hernández-Galdamez DR; González-Block MA; Romo-Dueñas DK; Cahuantzi-Tamayo RM; Texis-Morales O; Medina-Urzúa JJ; Cerón-Meza R; Hernández-Vicente IA; Lumbreras-Guzmán M Bol Med Hosp Infant Mex; 2023; 80(2):105-114. PubMed ID: 37155722 [TBL] [Abstract][Full Text] [Related]
5. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis. Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814 [TBL] [Abstract][Full Text] [Related]
6. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study. Sousa BLA; Brentani A; Costa Ribeiro CC; Dolhnikoff M; Grisi SJFE; Ferrer APS; Ferraro AA BMJ Open; 2021 Sep; 11(9):e050724. PubMed ID: 34489291 [TBL] [Abstract][Full Text] [Related]
7. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT. Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330 [TBL] [Abstract][Full Text] [Related]
8. Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study. Hernández-Vásquez A; Azañedo D; Vargas-Fernández R; Bendezu-Quispe G J Prev Med Public Health; 2020 Jul; 53(4):211-219. PubMed ID: 32752589 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with death in children with COVID-19 in Mexico. Rivas-Ruiz R; Roy-García IA; Ureña-Wong KR; Aguilar-Ituarte F; Anda GFV; Gutiérrez-Castrellón P; Mancilla-Ramírez J; Moreno-Espinosa S Gac Med Mex; 2020; 156(6):516-522. PubMed ID: 33877105 [TBL] [Abstract][Full Text] [Related]
10. Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging. Bello-Chavolla OY; González-Díaz A; Antonio-Villa NE; Fermín-Martínez CA; Márquez-Salinas A; Vargas-Vázquez A; Bahena-López JP; García-Peña C; Aguilar-Salinas CA; Gutiérrez-Robledo LM J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e52-e59. PubMed ID: 32598450 [TBL] [Abstract][Full Text] [Related]
11. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study. Serván-Mori E; Seiglie JA; Gómez-Dantés O; Wirtz VJ J Epidemiol Community Health; 2022 Jan; 76(1):16-23. PubMed ID: 34266980 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. Oliveira EA; Colosimo EA; Simões E Silva AC; Mak RH; Martelli DB; Silva LR; Martelli-Júnior H; Oliveira MCL Lancet Child Adolesc Health; 2021 Aug; 5(8):559-568. PubMed ID: 34119027 [TBL] [Abstract][Full Text] [Related]
13. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study. Vera-Zertuche JM; Mancilla-Galindo J; Tlalpa-Prisco M; Aguilar-Alonso P; Aguirre-García MM; Segura-Badilla O; Lazcano-Hernández M; Rocha-González HI; Navarro-Cruz AR; Kammar-García A; Vidal-Mayo JJ Epidemiol Infect; 2021 Apr; 149():e109. PubMed ID: 33913410 [TBL] [Abstract][Full Text] [Related]
14. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020). COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645 [TBL] [Abstract][Full Text] [Related]
15. Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York. Vasa A; Kini M; Neugarten J; Bellin E; Golestaneh L BMJ Open; 2022 Sep; 12(9):e063862. PubMed ID: 36581961 [TBL] [Abstract][Full Text] [Related]
16. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients. Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857 [TBL] [Abstract][Full Text] [Related]
17. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico. Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155 [TBL] [Abstract][Full Text] [Related]
18. A panoramic view of hospitalized young children in the metropolitan area of the valley of Mexico during COVID-19. Padilla-Rivas GR; Santoyo-Suarez MG; Benitez-Chao DF; Galan-Huerta K; Villareal HF; Garza-Treviño EN; Islas JF IJID Reg; 2023 Dec; 9():72-79. PubMed ID: 37928801 [TBL] [Abstract][Full Text] [Related]
19. Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages. Sosa-Rubí SG; Seiglie JA; Chivardi C; Manne-Goehler J; Meigs JB; Wexler DJ; Wirtz VJ; Gómez-Dantés O; Serván-Mori E Diabetes Care; 2021 Feb; 44(2):373-380. PubMed ID: 33208487 [TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Incidence and Outcomes Among Patients With COVID-19. Muñoz-Price LS; Nattinger AB; Rivera F; Hanson R; Gmehlin CG; Perez A; Singh S; Buchan BW; Ledeboer NA; Pezzin LE JAMA Netw Open; 2020 Sep; 3(9):e2021892. PubMed ID: 32975575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]